Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FUT5 | Q11128 | 1/20 | 0.53 |
| ▸ | NT5E | P21589 | 1/20 | 0.52 |
| ▸ | HPRT1 | P00492 | 3/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | TGM2 | P21980 | 1/20 | 0.49 |
| ▸ | HINT1 | P49773 | 1/20 | 0.48 |
| ▸ | F2 | P00734 | 1/20 | 0.47 |
| ▸ | STING1 | Q86WV6 | 2/20 | 0.47 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.47 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.47 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.46 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18521008 | 0.92 | FUT5 (0.55) | FUT5NT5EHPRT1POLBHPGD | |
| SCHEMBL30612754 | 0.89 | HPGD (0.54) | FUT5NT5EHPRT1HPGDHINT1 | |
| SCHEMBL21539237 | 0.88 | FUT5 (0.48) | FUT5NT5EHPRT1POLBHPGD | |
| SCHEMBL21539254 | 0.88 | FUT5 (0.50) | FUT5NT5EHPRT1POLBHPGD | |
| SCHEMBL12714572 | 0.88 | FUT5 (0.61) | FUT5NT5EHPRT1POLBTGM2 | |
| SCHEMBL20833471 | 0.88 | HPGD (0.51) | FUT5NT5EHPRT1POLBHPGD | |
| SCHEMBL12714575 | 0.88 | NT5E (0.68) | FUT5NT5EHPRT1POLBTGM2 | |
| SCHEMBL25711923 | 0.87 | HINT1 (0.50) | FUT5NT5EHPRT1HPGDHINT1 | |
| Phosphoric Acid SCHEMBL16213328 | 0.85 | NT5E (0.54) | FUT5NT5EHPRT1POLBHPGD | |
| SCHEMBL12714596 | 0.85 | FUT5 (0.66) | FUT5NT5EHPRT1POLBTGM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025103453-A1 | SIRNA FOR INHIBITING ANGIOTENSINOGEN EXPRESSION AND USE THEREOF | 纳肽得(青岛)生物医药有限公司 | 2025-05-22 | — | — | WO | claimed |
| WO-2025103457-A1 | SIRNA FOR INHIBITING LPA EXPRESSION AND USE THEREOF | 纳肽得(青岛)生物医药有限公司 | 2025-05-22 | — | — | WO | claimed |
| WO-2025103453-A1 | SIRNA FOR INHIBITING ANGIOTENSINOGEN EXPRESSION AND USE THEREOF | 纳肽得(青岛)生物医药有限公司 | 2025-05-22 | — | — | WO | disclosed |
| WO-2025103457-A1 | SIRNA FOR INHIBITING LPA EXPRESSION AND USE THEREOF | 纳肽得(青岛)生物医药有限公司 | 2025-05-22 | — | — | WO | disclosed |